Breast Cancer - Xconomy

Entry	Author	Date	Location
Will 3-D Thermal Imaging Revolutionize Breast Cancer Detection?	Sarah Schmid	05/18/12	Detroit
Genentech, ImmunoGen ‘Smart Bomb’ for Breast Cancer Clears Big Hurdle	Luke Timmerman	03/30/12	San Francisco
Genoa Pharma Aims To Satisfy Big Pharma’s Hunger for IPF Drugs	Luke Timmerman	03/30/12	San Diego
AIDS Drugs Were the Start. Let’s See More FDA Accelerated Approvals	Luke Timmerman	03/12/12	National
San Diego’s Aragon Raises $42 Million, Targets Hormone-Driven Cancers	Bruce V. Bigelow	03/06/12	San Diego
NanoString Nails Breast Cancer Study, Challenging Genomic Health	Luke Timmerman	12/08/11	Seattle
Genentech’s Two-Drug Strategy Raises the Bar in Breast Cancer	Luke Timmerman	12/07/11	San Francisco
Genomic Health Wins Medicare Coverage for High-Priced Colon Cancer Test	Luke Timmerman	09/30/11	San Francisco
Genentech, ImmunoGen’s Souped-Up Antibody for Breast Cancer Passes Key Test	Luke Timmerman	09/24/11	San Francisco
Former Genzyme Boss Henri Termeer Gives $10M to MGH for Personalized Medicine	Luke Timmerman	09/13/11	Boston
Lead Syndax Drug Shows Survival Benefits in Breast Cancer Trial	Arlene Weintraub	09/06/11	Boston
Video: Seattle Genetics CEO Makes the Case for a $100K Cancer Drug	Luke Timmerman	08/22/11	Seattle
Syndax Moves Closer to Pivotal Trials of Selective Lung Cancer Treatment	Arlene Weintraub	07/05/11	Boston
This Drug Didn’t Work for Me. May I Have My $88,000 Back, Please?	Stewart Lyman	06/30/11	Seattle
Genentech Shot Down at FDA Hearing on Avastin for Breast Cancer	Luke Timmerman	06/29/11	San Francisco
Atossa Nabs $6.6M	Luke Timmerman	06/27/11	Seattle
Hale, Royston Join Biocept Board	Bruce V. Bigelow	05/02/11	San Diego
KEW, Led by Millennium Co-Founder, Seeks to Bring Big-Time Cancer Care to Community Clinics	Ryan McBride	04/27/11	Boston
Think Obamacare Will Suffocate New Drug Development With Price Controls? Think Again	Luke Timmerman	03/21/11	National
ImmunoGen CEO Highlights Two New Souped-Up Antibodies Against Cancer	Ryan McBride	02/25/11	Boston
Gilead Bets $600M on Cancer, Genentech Gets a Hearing, Jennerex Shows Early Survival Edge, & More Bay Area Life Sciences News	Luke Timmerman	02/25/11	San Francisco
Genentech Gets FDA Hearing	Luke Timmerman	02/24/11	San Francisco
Sanofi Buys Genzyme for $20B, Aveo Inks Deal with Astellas, Hologix Nabs FDA Approval, & More Boston-Area Life Sciences News	Erin Kutz	02/18/11	Boston
Aveo Pharma Lands $1.4B Deal with Astellas, A Few Months Ahead of Cancer Trial Result	Ryan McBride	02/16/11	Boston
Genomic Health, Taking a Hit on Bottom Line, Bets Next-Gen Sequencing Will Yield Next-Gen Diagnostics	Luke Timmerman	02/15/11	San Francisco
Hologic Gets FDA Nod for 3-D Mammography	Gregory T. Huang	02/14/11	Boston
Adriana Jenkins, Boston Biotech PR Maven, Dies from Breast Cancer at 41	Luke Timmerman	02/10/11	Boston
NanoString, Snapping Up Genomic Health Veteran, Seeks to Prove Economic Value of Cancer Diagnostic	Luke Timmerman	02/03/11	Seattle
FDA To Yank Avastin Breast Cancer Approval	Luke Timmerman	12/16/10	San Francisco
Genomic Health Seeks to Build Momentum For Healthcare Shift from Rx to Dx	Luke Timmerman	11/08/10	San Francisco
Page 1 of 3	next page »

Entry

Author

Date

Location

Will 3-D Thermal Imaging Revolutionize Breast Cancer Detection?

Sarah Schmid

05/18/12

Detroit

Genentech, ImmunoGen ‘Smart Bomb’ for Breast Cancer Clears Big Hurdle

Luke Timmerman

03/30/12

San Francisco